“Illumina’s…presentations and product descriptions revealed a workflow that infringed on the ‘607, ‘138, ‘505, and ‘487 patents, 10x Genomics and Prognosys Biosciences argued.” On October 21, 10x ...
Xenium In Situ demonstrates higher transcript counts per gene in new comparison study of three spatial imaging platforms PLEASANTON, Calif., Dec. 13, 2023 /PRNewswire/ -- 10x Genomics, Inc. (TXG) ...
PLEASANTON, Calif. and PARIS, Nov. 6, 2023 /PRNewswire/ -- OWKIN and 10x Genomics, Inc. (TXG), announce they have entered into an agreement to add 10x Genomics spatial omics and single-cell ...
Computational assessment identifies probe binding errors in a widely used commercial platform for spatial transcriptomics.
The 10X Genomics Xenium Analyzer will support true single cell spatial transcriptomics on fresh frozen or fixed tissue samples. You can characterize 100s to 1000s of RNAs in cells and tissues using ...
Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling CareDx will ...
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, ...
Spatial Genomics Market to be Worth $3.23 Billion by 2031 - Exclusive Report by Meticulous Research®
REDDING, Calif., May 9, 2024 /PRNewswire/ -- According to a new market research report titled, 'Spatial Genomics Market by Type (Genomics, Transcriptomics) Technology (Sequencing, Imaging) Application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results